Evidence map›Paper›PMID 36866251›Full record

ArticleNanoscale advances2023

Magnetoresponsive fluorescent core-shell nanoclusters for biomedical applications.

Giovanni Marco Saladino, Ronak Kakadiya, Shaquib Rahman Ansari, Alexandra Teleki, Muhammet Sadaka Toprak

Abstract read
In one paragraph

Article in Nanoscale advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giovanni Marco SaladinoDepartment of Applied Physics, Biomedical and X-ray Physics, KTH Royal Institute of Technology SE 10691 Stockholm Sweden saladino@kth.se.ORCID https://orcid.org/0000-0002-6854-1423
Ronak KakadiyaDepartment of Applied Physics, Biomedical and X-ray Physics, KTH Royal Institute of Technology SE 10691 Stockholm Sweden saladino@kth.se.ORCID https://orcid.org/0000-0002-9273-4823
Shaquib Rahman AnsariDepartment of Pharmacy, Science for Life Laboratory, Uppsala University SE 75123 Uppsala Sweden.ORCID https://orcid.org/0000-0003-3710-405X
Alexandra TelekiDepartment of Pharmacy, Science for Life Laboratory, Uppsala University SE 75123 Uppsala Sweden.ORCID https://orcid.org/0000-0001-6514-8960
Muhammet Sadaka ToprakDepartment of Applied Physics, Biomedical and X-ray Physics, KTH Royal Institute of Technology SE 10691 Stockholm Sweden saladino@kth.se.ORCID https://orcid.org/0000-0001-5678-5298

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, superparamagnetic iron oxide nanoparticles (SPIONs) have a dominant role in many subfields of biomedicine. Owing to their peculiar properties, they can be employed for magnetic separation, drug delivery, diagnostics, and hyperthermia treatments. However, these magnetic nanoparticles (NPs) suffer from low unit magnetization due to size constraints (up to 20-30 nm) to exhibit superparamagnetic character. In this work, we have designed and synthesized superparamagnetic nanoclusters (SP-NCs) with diameters of up to 400 nm with high unit magnetization for enhanced loading capacity. These were synthesized with conventional or microwave-assisted solvothermal methods, in the presence of either of the two biomolecules (citrate or l-lysine) as the capping agent. Primary particle size, SP-NC size, surface chemistry, and the resultant magnetic properties were observed to be significantly influenced by the choice of synthesis route and capping agent. Selected SP-NCs were then coated with a fluorophore-doped silica shell to provide fluorescence properties, in the near-infrared spectrum region, while silica provided high chemical and colloidal stability. Heating efficiency studies were performed under alternating magnetic field on the synthesized SP-NCs, highlighting their potential in hyperthermia treatment. We envision that their enhanced magnetically-active content, fluorescence, magnetic property, and heating efficiency will pave the way to more effective uses in biomedical applications.

Identifiers

PMID36866251
PMCPMC9972542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.